Here are relevant reports on : influenza-vaccine-market
-
Military vaccination Market (Live attenuated Vaccine, Inactivated/Killed vaccine, Toxoid vaccine & Subunit/conjugate vaccine), Immunization ( active & passive), Troop health protection (First Aid & Surgical Instruments) & By Geography - Forecast & Analysis(2014-2020)
In armed forces across the globe, the armed personals are given vaccine and are immunized from the external viruses in order to continuously improve the readiness of the army men and women for any kind of emergency situations. It is very important to keep the armed personals healthy as they play a crucial role in safeguarding the people of the nations. To provide the healthy and protected environment for the defense personals and their families, the vaccines and the immunizing agents are provided to the armed personals at proper schedule or during the case of emergencies.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Vaccine Storage Equipment Market by Product (Refrigerator (Large & Small Capacity)), Freezer ((Low & Ultra-Low Temperature Freezer)), Vaccine Carrier/Cold Box, Monitoring Device ((Temperature Monitoring & Alarm)), Type, End User - Global Forecast to 2029
The global Vaccine Storage Equipment Market, valued at US$0.82 billion in 2023, stood at US$0.86 billion in 2024 and is projected to advance at a resilient CAGR of 7.2% from 2024 to 2029, culminating in a forecasted valuation of US$1.21 billion by the end of the period. The expansion of pharmaceutical manufacturing facilities across the globe, the increased demand for vaccines, and the rising need for temperature-controlled devices to store vaccines drive the growth of the vaccine storage equipment market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), ROA (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Vaccine (Human, Veterinary (Companion, Livestock)), Type (Organic, Inorganic) - Global Forecast to 2029
The global vaccine adjuvants market, valued at US$0.66 billion in 2023, stood at US$0.70 billion in 2024 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2029, culminating in a forecasted valuation of US$0.96 billion by the end of the period. Growing awareness about livestock health, increasing the adoption of companion animals and developing of therapeutic vaccines for cancer, allergies, and autoimmune disorders are creating lucrative growth opportunities
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Nucleic Acid Vaccine Market by Type, Application, End-User and Region - Global Forecast to 2030
The market outlook for nucleic acid vaccines is promising, with significant growth potential in the coming years. Nucleic acid vaccines, which include RNA (ribonucleic acid) and DNA (deoxyribonucleic acid) vaccines, have gained considerable attention due to their potential in addressing various diseases, including viral infections and certain types of cancer.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Influenza Diagnostics Market by Product (Test Kits, Instruments), Test Type (Traditional (RIDT, Viral Culture, Serological), Molecular (PCR, INAAT- NASBAT, TMABAS)), End User (Diagnostic Laboratories, Hospitals, Clinics) & Region - Global Forecast to 2026
The global influenza diagnostics market growth is primed to transition from $0.8 billion in 2021 to $1.1 billion by 2026, showcasing a strong CAGR of 7.7%. Key factors driving this growth include increasing demand for rapid disease diagnosis, rising influenza prevalence, and advancements in diagnostic technologies.
- Published: September 2021
- Price: $ 4950
- TOC Available:
-
Respiratory Antivirals Market by Disease Type (URTI, Influenza, Bronchiolitis, Pneumonia, Measles, & Others), Drug Class (Nucleoside Analogues, Neuraminidase Inhibitors, Ion Channel Blockers, Fusion Protein Inhibitors) - Global Forecast to 2019
Over the years, there has been a significant increase in the number of viral respiratory infections in humans. As a result of this, the costs to the community have increased considerably owing to the growing number of physician visits and hospitalizations. Among approximately 200 viral respiratory pathogens, the most important viral pathogens include influenza and respiratory syncytial viruses (RSVs). Antiviral drugs play an important role in the prevention and treatment of these disorders.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Asia Pacific cell culture Market, valued at US$6.49 billion in 2024, stood at US$6.98 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$12.40 billion by the end of the period. Biopharma companies in the region are expanding the production of monoclonal antibodies, vaccines, biosimilars, and recombinant proteins based on cell culture in the Asia Pacific cell culture market, which is thus growing.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Europe Cell Culture Market, valued at US$8.01 billion in 2024, stood at US$8.50 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.23 billion by the end of the period. The growth of the Europe cell culture market is driven by a strong and expanding biopharmaceutical sector, with rising production of biologics such as monoclonal antibodies, vaccines, and recombinant proteins that rely on sophisticated culture systems.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Tangential Flow Filtration Market by Product (Single Use Systems, Cassettes, Capsules), Material (PES, PVDF), Technique (Ultrafiltration), Application (Protein, Vaccine, API, Cell Separation), Scale of Operation (R&D), End User - Global Forecast to 2030
The global tangential flow filtration market, valued at US$1.76 billion in 2024, stood at US$1.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.20 billion by the end of the period. Several factors contribute to the growth of the tangential flow filtration market, including the increasing adoption of single-use technologies and the rising demand for scalable & high-throughput purification systems in biologics manufacturing.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Global Albumin Market, by Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin) by Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient) by Region - Forecast to 2022
The global albumin market is projected to grow at a CAGR of around 6% during the forecast period (2017-2022). Factors such as the high demand of albumin in R&D activities, rising non-therapeutic application of albumin, development of plant based albumin, rising production of immunoglobulins, and rise in plasma collection are driving the market. However, the stringent regulations, limited reimbursement, and irrational uses and adverse effects associated with albumin are the factors restraining the growth of this market.
- Published: April 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
